J
Jinghua Peng
Researcher at Shanghai University
Publications - 52
Citations - 1336
Jinghua Peng is an academic researcher from Shanghai University. The author has contributed to research in topics: Fatty liver & Liver injury. The author has an hindex of 15, co-authored 48 publications receiving 1009 citations.
Papers
More filters
Journal ArticleDOI
Roles of Chlorogenic Acid on Regulating Glucose and Lipids Metabolism: A Review
TL;DR: This review addresses current studies investigating the roles of CGA in glucose and lipid metabolism and indicates that CGA exerts many biological properties, including antibacterial, antioxidant, and anticarcinogenic activities.
Journal ArticleDOI
Gut Microbial Dysbiosis Is Associated with Altered Hepatic Functions and Serum Metabolites in Chronic Hepatitis B Patients.
Jing Wang,Yang Wang,Xu Zhang,Jiaqi Liu,Qianpeng Zhang,Yu Zhao,Jinghua Peng,Qin Feng,Jian-ye Dai,Shu-jun Sun,Yufeng Zhao,Liping Zhao,Yongyu Zhang,Yongyu Zhang,Yi-Yang Hu,Menghui Zhang +15 more
TL;DR: In this article, the compositional and functional changes in the gut microbiota in early stage chronic hepatitis B (CHB) patients suggest the potential contributions of gut microbiota to the progression of CHB, and thus provide new insight into gut microbiota-targeted interventions to improve the prognosis of this disease.
Journal ArticleDOI
Structural changes of gut microbiota in a rat non-alcoholic fatty liver disease model treated with a Chinese herbal formula.
Xiaochen Yin,Jinghua Peng,Liping Zhao,Liping Zhao,Yunpeng Yu,Xu Zhang,Ping Liu,Qin Feng,Yi-Yang Hu,Xiaoyan Pang +9 more
TL;DR: The results revealed that the bacterial profiles of HFD-induced rats could be modulated by theCHF, and differences in microbiota composition provided a basis for further understanding the pharmacological mechanism of the CHF.
Journal ArticleDOI
Anti-fibrotic effect of Cordyceps sinensis polysaccharide: Inhibiting HSC activation, TGF-β1/Smad signalling, MMPs and TIMPs.
TL;DR: It is indicated that the effects of CS-PS anti-liver fibrosis are probably associated with the inhibition on HSC activation, TGF-β1/Smads signalling pathway, as well as MMP2, MMP9 activity and TIMP2 expression.
Journal ArticleDOI
Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways.
Xue-mei Li,Jinghua Peng,Zhaolin Sun,Hua-jie Tian,Xiao-hua Duan,Lin Liu,Xin Ma,Qin Feng,Ping Liu,Yi-Yang Hu +9 more
TL;DR: Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats, and this effect was likely associated with the down-regulation of MMP2/9 activities, TIMP1/2 protein expression and the TGF-β1/Smad signaling pathways in the liver.